These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11922953)

  • 21. Pharmacophore modeling for ADME.
    Guner OF; Bowen JP
    Curr Top Med Chem; 2013; 13(11):1327-42. PubMed ID: 23675939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new standardized electrochemical array for drug metabolic profiling with human cytochromes P450.
    Fantuzzi A; Mak LH; Capria E; Dodhia V; Panicco P; Collins S; Gilardi G
    Anal Chem; 2011 May; 83(10):3831-9. PubMed ID: 21469680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
    Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
    Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating human P450s involved in drug metabolism via homology with high-resolution P450 crystal structures of the CYP2C subfamily.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Drug Metab; 2006 Aug; 7(6):589-98. PubMed ID: 16918314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational prediction of drug binding and rationalisation of selectivity towards cytochromes P450.
    Stjernschantz E; Vermeulen NP; Oostenbrink C
    Expert Opin Drug Metab Toxicol; 2008 May; 4(5):513-27. PubMed ID: 18484912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining in silico protein stability calculations with structure-function relationships to explore the effect of polymorphic variation on cytochrome P450 drug metabolism.
    Arendse L; Blundell TL; Blackburn J
    Curr Drug Metab; 2013 Sep; 14(7):745-63. PubMed ID: 23826828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward reduction in animal sacrifice for drugs: molecular modeling of Macaca fascicularis P450 2C20 for virtual screening of Homo sapiens P450 2C8 substrates.
    Rua F; Di Nardo G; Sadeghi SJ; Gilardi G
    Biotechnol Appl Biochem; 2012; 59(6):479-89. PubMed ID: 23586958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans.
    Danielson PB
    Curr Drug Metab; 2002 Dec; 3(6):561-97. PubMed ID: 12369887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate.
    Lewis DF; Eddershaw PJ; Dickins M; Tarbit MH; Goldfarb PS
    Chem Biol Interact; 1998 Oct; 115(3):175-99. PubMed ID: 9851289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 57 varieties: the human cytochromes P450.
    Lewis DF
    Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 networks in chemical space.
    Lee S; Kim D
    Arch Pharm Res; 2010 Sep; 33(9):1361-74. PubMed ID: 20945135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.
    Gay SC; Roberts AG; Halpert JR
    Future Med Chem; 2010 Sep; 2(9):1451-68. PubMed ID: 21103389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6.
    de Groot MJ; Ackland MJ; Horne VA; Alex AA; Jones BC
    J Med Chem; 1999 May; 42(9):1515-24. PubMed ID: 10229622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.
    Ekins S; de Groot MJ; Jones JP
    Drug Metab Dispos; 2001 Jul; 29(7):936-44. PubMed ID: 11408357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key substrate recognition residues in the active site of a plant cytochrome P450, CYP73A1. Homology guided site-directed mutagenesis.
    Schoch GA; Attias R; Le Ret M; Werck-Reichhart D
    Eur J Biochem; 2003 Sep; 270(18):3684-95. PubMed ID: 12950252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug metabolism by cytochromes P450 in the liver and small bowel.
    Watkins PB
    Gastroenterol Clin North Am; 1992 Sep; 21(3):511-26. PubMed ID: 1516957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and pharmacophore insights into CYP3A enzymes.
    Ekins S; Stresser DM; Williams JA
    Trends Pharmacol Sci; 2003 Apr; 24(4):161-6. PubMed ID: 12707001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.